Catalyst Wire Dossier Catalyst Wire Dossier

ESO-1 lymphocytes

ESO-1 lymphocytes
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ESO-1 lymphocytes, covering 2016-06-27 to 2016-06-27. Get the full timeline:

Most recent: Clinical Trial Update: Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer [Phase 2]

See pricing